Aligos Therapeutics, Inc. (ALGS) Total assets 2020–2025
Aligos Therapeutics, Inc. (ALGS) total assets at each fiscal year-end, per SEC filings.
$88.5MFY2025 · since FY2020: $265.3M → $88.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $88.5M | +26.3% |
| FY2024 | $70.1M | -53.7% |
| FY2023 | $151.5M | +3.3% |
| FY2022 | $146.7M | -37.7% |
| FY2021 | $235.4M | -11.3% |
| FY2020 | $265.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ALGS financial trends
ALGS RevenueALGS Net incomeALGS Net marginALGS Gross profitALGS Gross marginALGS Operating incomeALGS Operating marginALGS Operating cash flowALGS Free cash flowALGS Capital expendituresALGS Return on equityALGS Stock buybacksALGS Dividends paidALGS Total liabilitiesALGS Shareholders’ equityALGS overview →